Stock analysts at William Blair decreased their Q1 2025 earnings per share (EPS) estimates for CSG Systems International in a research note issued on Thursday, February 6th. William Blair analyst M.

Equities research analysts at William Blair cut their Q1 2025 earnings estimates for Encompass Health in a report released on Friday, February 7th. William Blair analyst J. Haase now expects that the ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

Fintel reports that on February 7, 2025, William Blair initiated coverage of Rubrik (NYSE:RBRK) with a Market Perform ...

William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

William Blair initiated coverage of Rubrik (RBRK) with a Market Perform rating.Maximize Your Portfolio with Data Driven Insights:Leverage the ...